Exchange Traded Concepts, LLC Uni Qure N.V. Transaction History

Exchange Traded Concepts, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$18.12 - $27.32 $18,409 - $27,757	1,016 Added 3.45%	30,481 $691,000
Q3 2022 Oct 07, 2022	BUY	$16.98 - $25.54 $500,315 - $752,536	29,465 New	29,465 $553,000
Q2 2022 Jul 20, 2022	SELL	$13.15 - $20.45 $389,266 - $605,360	-29,602 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$14.54 - $21.5 $430,413 - $636,443	29,602 New	29,602 $535,000

155

40.8M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $657M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.